Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Palisade Bio Inc (NASDAQ: PALI) closed the day trading at $2.09 up 0.48% from the previous closing price of $2.08. In other words, the price has increased by $0.48 from its previous closing price. On the day, 4.01 million shares were traded. PALI stock price reached its highest trading level at $2.19 during the session, while it also had its lowest trading level at $2.02.
Ratios:
For a better understanding of PALI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PALI now has a Market Capitalization of 311834720 and an Enterprise Value of 306402720.
Stock Price History:
The Beta on a monthly basis for PALI is 1.47, which has changed by 0.17514122 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, PALI has reached a high of $2.59, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 9.62%, while the 200-Day Moving Average is calculated to be 91.87%.
Shares Statistics:
Over the past 3-months, PALI traded about 8.92M shares per day on average, while over the past 10 days, PALI traded about 6330860 shares per day. A total of 149.00M shares are outstanding, with a floating share count of 139.74M. Insiders hold about 6.22% of the company’s shares, while institutions hold 38.39% stake in the company. Shares short for PALI as of 1764288000 were 13976371 with a Short Ratio of 1.57, compared to 1761868800 on 7594147. Therefore, it implies a Short% of Shares Outstanding of 13976371 and a Short% of Float of 9.379999999999999.
Earnings Estimates
The market rating of Palisade Bio Inc (PALI) is currently shaped by the ongoing analysis conducted by 3.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.18 and -$1.48 for the fiscal current year, implying an average EPS of -$0.65. EPS for the following year is -$0.19, with 3.0 analysts recommending between -$0.09 and -$0.33.
